Millions of Americans with depression function perfectly well using common treatments, but there are those whose disease shows resistance to most drug...
The U.S. Food and Drug Administration (FDA) this week approved the first generic versions of the antidepressant duloxetine, commonly marketed as Cymba...
The U.S. Food and Drug Administration (FDA) today announced that it has approved vortioxetine, a new medication to treat major depressive disorder in ...
A doctor writing for the British Medial Journal (BMJ) has stated that antidepressants are overprescribed. His views are part of a debate on the BMJ we...
A new study has discovered a cognitive biomarker in teens that could identify those who are at high risk for future depression and anxiety. The marker...